Featured Topics
ar-2024-teaser-board-of-management-watermark-overlay-left
March 5, 2025
FY and Q4 2024 Reporting
Calendar

March 05, 2025

FY/Q4 2024 Results / Annual Report
Press Releases
Share Price / Index
February 11, 2025
Not intended for U.S. and UK Media
Heart drug Beyonttra™ (acoramidis) approved in EU for treatment of transthyretin amyloidosis in adults with cardiomyopathy
February 10, 2025
Not intended for U.S. and UK Media
Bayer files for approval of extended 6-month treatment interval for Eylea™ 8 mg in the EU
February 03, 2025
Not intended for U.S. and UK Media
Bayer files for approval of finerenone in heart failure in the EU

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.